Different Takes: The Future Of Covid Is Not Promising; Is It Time To Start Masking Again?


Opinion writers examine covid, monkeypox and mental health.


San Francisco Chronicle:
COVID Keeps Evolving. Clinical Drug Trials Need To Evolve Along With It


Alpha. Beta. Delta. Omicron. BA.5. The list of COVID variants and subvariants continues to grow. And the threat of prolonged symptoms from long COVID becomes clearer every day. Our best defense — research to produce new and effective treatments — must keep advancing. But our clinical research system has a problem, and the Food and Drug Administration is only now making some headway in trying to fix it. (Tom Rico Pamukcu, 7/19)

Also —


Bloomberg:
Monkeypox Treatments Aren’t Getting Enough Scrutiny


As monkeypox cases multiply in the US, more research is needed to assess how well existing treatments work. Unfortunately, no efforts are yet underway to conduct the kind of clinical trials that might let doctors know how much antiviral drugs improve patients’ lives. (Lisa Jarvis, 7/20)


This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.



Source link

Ozinize
Logo
Shopping cart